(2009; 70 pages)
This report presents the results of transparency assessments carried out in Jordan. It provides a comprehensive picture of the level of transparency and the potential vulnerability to corruption of six essential functions of the public pharmaceutical sector - registration, promotion, inspection, selection, procurement and distribution of medicines.
The methodology provides both qualitative and quantitative information. Two national investigators nominated from the Jordan Food and Drug Administration (JFDA) and from the Ministry of Health (national assessor plus co-assessor) collected data by conducting a series of interviews with carefully selected key informants. The information collected was then converted using a rough quantification method into a zero to 10 scale, to provide a score for each function in terms of vulnerability to corruption (minimal to extreme). The scoring indicates vulnerability in terms of the policy, the regulatory and administrative structures and the procedures at the time of the survey.
The quantitative data reveal that the areas of medicine distribution and procurement received the highest scores and are minimally vulnerable to corruption; medicines registration and selection are marginally vulnerable to corruption; medicine inspection is moderately vulnerable to corruption; while, medicine promotion had the lowest score and is extremely vulnerable to corruption...